Archiv der Pharmazie

短名Arch Pharm
Journal Impact4.49
国际分区PHARMACOLOGY & PHARMACY(Q1)
期刊索引SCI Q1中科院 3 区
ISSN0365-6233, 1521-4184
h-index73
国内分区医学(3区)医学化学综合(2区)医学药学(2区)医学药物化学(3区)

ARCHIV DER PHARMAZIE - CHEMISTRY IN LIFE SCIENCES 是一份致力于药物和药物化学各个领域研究和开发的国际期刊。重点放在将合成有机化学、结构生物学、分子建模、生物有机化学、天然产物化学、生物化学或分析方法与生物活性等药物或医学方面相结合的论文。该期刊的重点是原创研究论文,但也欢迎其他具有科学价值的贡献(例如评论、小型评论、亮点、专题讨论会贡献、讨论和论文)。

期刊主页投稿网址
涉及主题化学立体化学
出版信息出版商: Wiley-VCH Verlag出版周期: Monthly期刊类型: journal
基本数据创刊年份: 1950原创研究文献占比80.49%自引率:4.70%Gold OA占比: 17.00%
平均审稿周期 网友分享经验:平均3.0个月
平均录用比例网友分享经验:较易

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

New hydrazide derivatives of <i>N</i>‐amino‐11‐azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple‐negative breast cancer

2024-9-13

In vitro assessment of skin permeation properties of enzymatically derived oil‐based fatty acid esters of vitamin C

2024-9-13

Repurposing antiparasitic <i>N,N′</i>‐aliphatic diamine derivatives as promising antimycobacterial agents

2024-9-12

Amorphous silica nanoparticles exhibit antitumor activity in triple‐negative breast cancer cells

2024-9-10

Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies

2024-9-6

<i>Hibiscus schizopetalus</i> boosts wound healing via restoring redox balance and hindering inflammatory responses in rats: Insights on metabolome profiling and molecular docking

2024-9-6

From dyes to drugs: The historical impact and future potential of dyes in drug discovery

2024-9-6

Exploring the chemical space around chrysin to develop novel vascular Ca<sub>V</sub>1.2 channel blockers, promising vasorelaxant agents

2024-9-6

Insights into medicinal attributes of imidazo[1,2‐<i>a</i>]pyridine derivatives as anticancer agents

2024-9-2

Issue Information: Arch Pharm (9/2024)

2024-9-1

Cyclization of acyl thiosemicarbazides led to new <i>Helicobacter pylori</i> α‐carbonic anhydrase inhibitors

2024-8-29

DNA interaction of selected tetrahydropyrimidine and its effects against CCl<sub>4</sub>‐induced hepatotoxicity in vivo: Part II

2024-8-27

Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from <i>Aspergillus oryzae</i> N12: Repurposing of a dermo‐cosmetic lead

2024-8-23

MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions

2024-8-23

Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease

2024-8-15

An in‐depth analysis of COVID‐19 treatment: Present situation and prospects

2024-8-6

Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells

2024-8-6

Synthesis, in vitro anticancer activity, and pharmacokinetic profiling of the new tetrahydropyrimidines: Part I

2024-8-5

Facile one‐pot synthesis of <i>N‐</i>pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug‐resistant <i>Staphylococcus aureus</i>

2024-8-5

Issue Information: Arch Pharm (8/2024)

2024-8-1

Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFR<sup>T790M</sup>: Molecular docking, ADMET, design, and syntheses

2024-8-1

Unlocking the potential of edible <i>Ulva</i> sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management

2024-7-31

Mono‐ and bis(steroids) containing a cyclooctane core: Synthesis, antiproliferative activity, and action on cell cytoskeleton microtubules

2024-7-30

Tail‐approach based design, synthesis, and molecular modeling of benzenesulfonamides carrying thiadiazole and urea moieties as novel carbonic anhydrase inhibitors

2024-7-30

Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade

2024-7-29

Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?

2024-7-29

Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines

2024-7-26

Natural flavonoids as promising lactate dehydrogenase A inhibitors: Comprehensive in vitro and in silico analysis

2024-7-25

CAPE derivatives: Multifaceted agents for chronic wound healing

2024-7-25

New potent muscarinic receptor ligands bearing the 1,4‐dioxane nucleus: Investigation on the nature of the substituent in position 2

2024-7-25

Correction to: Ecofriendly synthesis of pyrano[2,3‐<i>d</i>]pyrimidine derivatives and related heterocycles with anti‐inflammatory activities

2024-7-24

Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review

2024-7-23

Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity

2024-7-23

<i>Peperomia pellucida</i> (L.) <scp>Kunth</scp> suppresses glycation‐induced inflammatory response in human retinal pigment epithelial cell line ARPE‐19 via JAK‐STAT3 signaling

2024-7-22

Novel 1,2,4‐triazole derivatives containing the naphthalene moiety as selective butyrylcholinesterase inhibitors: Design, synthesis, and biological evaluation

2024-7-21

Structural characterization and bioactivity profiling of the fungal peptaibiotic tolypin reveal protective effects against influenza viruses

2024-7-19

New labdane diterpenoids from <i>Alpinia galanga</i>: A new type of GLP‐1 secretagogues targeting the PKA‐CREB and PI3K‐Akt signaling axes

2024-7-19

A critical review of therapeutic interventions in sickle cell disease: Progress and challenges

2024-7-19

Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐<i>b</i>]pyridazine hybrid derivatives as VEGFR selective inhibitors

2024-7-15

Caffeic acid and its derivative caffeic acid phenethyl ester as potential therapeutic compounds for cardiovascular diseases: A systematic review

2024-7-15

Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases

2024-7-14

Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity

2024-7-12

Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies

2024-7-12

Novel thiazolotriazole and triazolothiadiazine scaffolds as selective tumor associated carbonic anhydrase inhibitors endowed with cathepsin B inhibition

2024-7-11

Current scenario of indole hybrids with antibacterial potential against <i>Acinetobacter baumannii</i> pathogens: A mini‐review

2024-7-10

Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents

2024-7-9

The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review

2024-7-9

Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents

2024-7-5

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司